Skip to main content
Funded Studies

Liat Mintz, PhD


Location: East Brunswick, NJ United States


Dr. Mintz received her PhD from Tel-Aviv University in immunology and cell research. She established and headed the Bioinformatics Unit at Tel-Aviv University. Dr. Mintz was a member of the founding team of Compugen Ltd. As head of the genomics research she established and managed Compugen’s molecular biology lab and bioinformatics unit. She was responsible for converting Compugen’s bioinformatics discoveries into biological entities. Dr. Mintz is a pioneer in the discovery of splice variants and an inventor of more than 30 U.S. and international patents. After leaving Compugen Dr. Mintz founded DiaLean Ltd., a company that develops peptide therapeutics based on novel proteins discovered using proprietary bioinformatics methodologies. Dln-101, DiaLean’s lead molecule, is being developed for the treatment of Parkinson's disease.


Associated Grants

  • DLN-101 for the Treatment of Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.